Blueprint Medicines, a Sanofi Company, Announces Four-Year PIONEER Data Showing Sustained Benefit and Long-Term Safety of AYVAKIT(R) (avapritinib) in Indolent Systemic Mastocytosis

Blueprint Medicines, a Sanofi company, today announced AYVAKIT(R) (avapritinib) data showing clinically meaningful outcomes and a w ...
Yahoo Malaysia

The #1 Fruit to Help You Poop, According to Dietitians

Kiwi’s fiber and water content can help make stool easier to pass. Kiwi contains a digestive enzyme that may help keep food ...
Opinion

The education system should work in favour of middle-class families who fight for their children’s betterment - David Behrens

This is an anxious weekend for many parents. After months of biting their nails and sometimes years of sacrifice, they will wake on Monday to the results of Britain’s most contentious annual lottery.
The Malaysian Reserve

Blueprint Medicines, a Sanofi Company, Announces Four-Year PIONEER Data Showing Sustained Benefit and Long-Term Safety of AYVAKIT® (avapritinib) in Indo…

Real-world study of AYVAKIT highlights improvement across ISM symptoms ---- 12 data presentations at 2026 AAAAI Annual ...